Y. Gao, P. Wang, J. Lu, B. Pan, D. Guo, Z. Zhang, A. Wang, M. Zhang, J. Sun, W. Wang, Z. Liang, Diagnostic significance of parafibromin expression in parathyroid carcinoma. Hum. Pathol. 127, 28–38 (2022). https://doi.org/10.1016/j.humpath.2022.05.014

Article  CAS  PubMed  Google Scholar 

S. Leonard-Murali, T. Ivanics, D.S. Kwon, X. Han, C.P. Steffes, R. Shah, Local resection versus radical surgery for parathyroid carcinoma: a national cancer database analysis. Eur. J. Surg. Oncol. 47, 2768–2773 (2021). https://doi.org/10.1016/j.ejso.2021.06.026

Article  PubMed  PubMed Central  Google Scholar 

W.M. Lo, M.L. Good, N. Nilubol, N.D. Perrier, D.T. Patel, Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma. Ann. Surg. Oncol. 25, 2535–2540 (2018). https://doi.org/10.1245/s10434-018-6559-6

Article  PubMed  PubMed Central  Google Scholar 

L.K. Long, R.S. Sippel, Current and future treatment for parathyroid carcinoma. Int. J. Endo. Oncol. 5(1), IJE06 (2018). https://doi.org/10.2217/ije-2017-0011

Article  CAS  Google Scholar 

C.N. Clarke, P. Katsonis, T.K. Hsu, A.M. Koire, A. Silva-Figueroa, I. Christakis, M.D. Williams, M. Kutahyalioglu, L. Kwatampora, Y. Xi, J.E. Lee, E.S. Koptez, N.L. Busaidy, N.D. Perrier, O. Lichtarge, Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways. J. Endocr. Soc. 3(3), 544–559 (2018). https://doi.org/10.1210/js.2018-00043

Article  CAS  PubMed  PubMed Central  Google Scholar 

F. Marini, F. Giusti, G. Palmini, G. Perigli, R. Santoro, M.L. Brandi, Genetics and epigenetics of parathyroid carcinoma. Front. Endocrinol. 13, 834362 (2022). https://doi.org/10.3389/fendo.2022.834362

Article  Google Scholar 

N.D. Perrier, A. Arnold, J. Costa-Guda, N.L. Busaidy, H. Nguyen, H.H. Chuang, M.L. Brandi, Hereditary endocrine tumours: current state-of-the-art and research opportunities: new and future perspectives for parathyroid carcinoma. Endocr. Relat. Cancer 27(8), T53–T63 (2020). https://doi.org/10.1530/ERC-20-0018

Article  PubMed  Google Scholar 

R. Uljanovs, S. Sinkarevs, B. Strumfs, L. Vidusa, K. Merkurjeva, I. Strumfa, Immunohistochemical profile of parathyroid tumours: a comprehensive review. Int. J. Mol. Sci. 23(13), 6981 (2022). https://doi.org/10.3390/ijms23136981

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Pandya, A.V. Uzilov, J. Bellizzi, C.Y. Lau, A.S. Moe, M. Strahl, W. Hamou, L.C. Newman, M.Y. Fink, Y. Antipin, W. Yu, M. Stevenson, B.M. Cavaco, B.T. The, R.V. Thakker, H. Morreau, E.E. Schadt, R. Sebra, S.D. Li, A. Arnold, R. Chen, Genomic profiling reveals mutational landscape in parathyroid carcinomas. Jci. Insight 2(6), e92061 (2017). https://doi.org/10.1172/jci.insight.92061

Article  PubMed  PubMed Central  Google Scholar 

L. Zhao, L.H. Sun, D.M. Liu, X.Y. He, B. Tao, G. Ning, J.M. Liu, H.Y. Zhao, Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma. World J. Surg. 38(7), 1730–1737 (2014). https://doi.org/10.1007/s00268-014-2455-9

Article  PubMed  Google Scholar 

H.S. Park, Y.H. Lee, N. Hong, D. Won, Y. Rhee, Germline mutations related to primary hyperparathyroidism identified by next-generation sequencing. Front. Endocrinol. 13, 853171 (2022). https://doi.org/10.3389/fendo.2022.853171

Article  Google Scholar 

Y. Hu, X. Zhang, O. Wang, Y. Bi, X. Xing, M. Cui, M. Wang, W. Tao, Q. Liao, Y. Zhao, The genomic profile of parathyroid carcinoma based on whole-genome sequencing. Int. J. Cancer 147(9), 2446–2457 (2020). https://doi.org/10.1002/ijc.33166

Article  CAS  PubMed  Google Scholar 

H. Kang, D. Pettinga, A.D. Schubert, P.W. Ladenson, D.W. Ball, J.H. Chung, A.B. Schrock, R. Madison, G.M. Frampton, P.J. Stephens, J.S. Ross, V.A. Miller, S.M. Ali, Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy. Oncologist 24(6), 791–797 (2019). https://doi.org/10.1634/theoncologist.2018-0334

Article  CAS  PubMed  Google Scholar 

M. Kutahyalioglu, H.T. Nguyen, L. Kwatampora, C. Clarke, A. Silva, E. Ibrahim, S.G. Waguespack, M.E. Cabanillas, C. Jimenez, M.I. Hu, S.I. Sherman, S. Kopetz, R. Broaddus, R. Dadu, K. Wanland, M. Williams, M. Zafereo, N. Perrier, N.L. Busaidy, Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J. Cancer Res. Clin. Oncol. 145(8), 1977–1986 (2019)

Article  PubMed  Google Scholar 

H.L. Robbins, A. Hague, The PI3K/Akt pathway in tumors of endocrine tissues. Front. Endocrinol. 6, 188 (2015). https://doi.org/10.1007/s00432-019-02945-9

Article  Google Scholar 

S.H. Kong, Updates of genomics and proteomics of parathyroid carcinoma. Endocrines 3, 745–752 (2022). https://doi.org/10.3390/endocrines3040061

Article  CAS  Google Scholar 

A. Riccardi, C. Lemos, R. Ramos, J. Bellizzi, K. Parham, T.C. Brown, R. Korah, T. Carling, J. Costa-Guda, A. Arnold, PIK3CA mutational analysis of parathyroid adenomas. JBMR 4(6), e10360 (2020). https://doi.org/10.1002/jbm4.10360

Article  CAS  Google Scholar 

T. Zhan, N. Rindtorff, M. Boutros, Wnt signaling in cancer. Oncogene 36, 1461–1473 (2017). https://doi.org/10.1038/onc.2016.304

Article  CAS  PubMed  Google Scholar 

J. Svedlund, M. Aurén, M. Sundström, H. Dralle, G. Akerström, P. Björklund, G. Westin, Aberrant WNT/β-catenin signaling in parathyroid carcinoma. Mol. Cancer 9, 294 (2010). https://doi.org/10.1186/1476-4598-9-294

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Svedlund, E. Barazeghi, P. Stålberg, P. Hellman, G. Åkerström, P. Björklund, G. Westin, The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors. Endocr. Relat. Cancer 21(2), 231–239 (2014). https://doi.org/10.1530/ERC-13-0497

Article  CAS  PubMed  Google Scholar 

L. Sulaiman, C.C. Juhlin, I.L. Nilsson, O. Fotouhi, C. Larsson, J. Hashemi, Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics 8, 646–655 (2013). https://doi.org/10.4161/epi.24823

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.F. Starker, J. Svedlund, R. Udelsman, H. Dralle, G. Akerström, G. Westin, R.P. Lifton, P. Björklund, T. Carling, The DNA methylome of benign and malignant parathyroid tumors. Genes. Chromosomes Cancer 50, 735–745 (2011). https://doi.org/10.1002/gcc.20895

Article  CAS  PubMed  PubMed Central  Google Scholar 

C.C. Juhlin, N.B. Kiss, A. Villablanca, F. Haglund, J. Nordenström, A. Höög, C. Larsson, Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS ONE 5, e9472 (2010). https://doi.org/10.1371/journal.pone.0009472

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Svedlund, S. Koskinen Edblom, V.E. Marquez, G. Åkerström, P. Björklund, G. Westin, Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification. J. Clin. Endocrinol. Metab. 2012(97), E1307–E1315 (2012). https://doi.org/10.1210/jc.2011-3136

Article  CAS  Google Scholar 

S. Corbetta, V. Vaira, V. Guarnieri, A. Scillitani, C. Eller-Vainicher, S. Ferrero, L. Vicentini, I. Chiodini, M. Bisceglia, P. Beck-Peccoz, S. Bosari, A. Spada, Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr. Relat. Cancer 17(1), 135–146 (2010). https://doi.org/10.1677/ERC-09-0134

Article  CAS  PubMed  Google Scholar 

S. Liu, Z. Wang, Z. Liu, S. Shi, Z. Zhang, J. Zhang, H. Lin, miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. J. Mol. Cell. Biol. 10(4), 302–315 (2018). https://doi.org/10.1093/jmcb/mjy041

Article  CAS  PubMed  Google Scholar 

F. Marini, F. Giusti, G. Palmini, C. Aurilia, S. Donati, M.L. Brandi, Parathyroid carcinoma: update on pathogenesis and therapy. Endocrines 4(1), 205–235 (2023). https://doi.org/10.3390/endocrines4010018

Article  CAS  Google Scholar 

B. Guan, J.M. Welch, J.C. Sapp, H. Ling, Y. Li, J.J. Johnston, E. Kebebew, L.G. Biesecker, W.F. Simonds, S.J. Marx, S.K. Agarwal, GCM2-activating mutations in familial isolated hyperparathyroidism. Am. J. Hum. Genet. 99(5), 1034–1044 (2016). https://doi.org/10.1016/j.ajhg.2016.08.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Canaff, V. Guarnieri, Y. Kim, B.Y.L. Wong, A. Nolin-Lapalme, D.E.C. Cole, S. Minisola, C. Eller-Vainicher, F. Cetani, A. Repaci, D. Turchetti, S. Corbetta, A. Scillitani, D. Goltzman, Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders. Eur. J. Endocrinol. 186(3), 351–366 (2022). https://doi.org/10.1016/10.1530/EJE-21-0433

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Song, Y. Yang, Y. Wang, S. Liu, M. Nie, Y. Jiang, M. Li, W. Xia, O. Wang, X. Xing, Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients. Endocr. Pract. 26(10), 1093–1104 (2020). https://doi.org/10.4158/EP-2020-0132

Article  PubMed  Google Scholar 

R. Rahbari, A.K. Holloway, M. He, E. Khanafshar, O.H. Clark, E. Kebebew, Identification of differentially expressed microRNA in parathyroid tumors. Ann. Surg. Oncol. 18(4), 1158–1165 (2011). https://doi.org/10.1245/s10434-010-1359-7

Article  PubMed  Google Scholar 

J. Krupinova, N. Mokrysheva, V. Petrov, E. Pigarova, A. Eremkina, E. Dobreva, A. Ajnetdinova, G. Melnichenko, A. Tiulpakov, Serum circulating miRNA-342-3p as a potential diagnostic biomarker in parathyroid carcinomas: a pilot study. Endocrinol. Diabetes Metab. 4(4), e00284 (2021). https://doi.org/10.1002/edm2.284

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Verdelli, I. Forno, V. Vaira, S. Corbetta, MicroRNA deregulation in parathyroid tumours suggests an embryonic signature. J. Endocrinol. Investig. 38(4), 383–388 (2015). https://doi.org/10.1007/s40618-014-0234-y

Article  CAS  Google Scholar 

A. Morotti, I. Forno, C. Verdelli, V. Guarnieri, F. Cetani, A. Terrasi, R. Silipigni, S. Guerneri, V. Andrè, A. Scillitani, L. Vicentini, S. Ferrero, S. Corbetta, V. Vaira, The oncosuppressors MEN1 and CDC73 are involved in lncRNA deregulation in human parathyroid tumors. J. Bone Miner. Res 35(12), 2423–2431 (2020). https://doi.org/10.1002/jbmr.4154